Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
Ruminant BioTech has raised $9.5M in total funding. The most recent round was Series A. The last funding was announced in November 2025.
Ruminant BioTech's investors include Rosrain Investments, Marex, Regeneration.VC, AgriZeroNZ, Australian Government.
Ruminant BioTech is headquartered in Port Waikato, New Zealand.
Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
Ruminant BioTech is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ruminant BioTech — Funding & Investors." VCBacked, November 25, 2025, https://www.vcbacked.co/company/ruminant-biotech. Accessed August 2, 2026.
VCBacked. (2025). Ruminant BioTech — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/ruminant-biotech
{{cite web |title=Ruminant BioTech — Funding & Investors |url=https://www.vcbacked.co/company/ruminant-biotech |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated